StartAngels Network

StartAngels Network is an angel investment firm located in Zurich, Switzerland, established in 1999. The firm specializes in providing investment consulting services and focuses on sectors such as medtech, information and communication technology (ICT), clean technology, instruments, micro-technology, and nanotechnology. Through its investment activities, StartAngels Network aims to support innovative startups and entrepreneurs within these industries.

Erich Platzer

Board of Director

25 past transactions

myFacility

Seed Round in 2022
Oxfia is an energy optimization platform. It can optimize and monitor existing building technology without human interaction and lower energy costs in the building process. They specialize in reducing carbon dioxide emissions and energy costs associated with the operation of building systems, enabling people to minimize their building's energy costs and reduce controllable energy consumption.

Pipra

Seed Round in 2022
PIPRA AG (Pre-Interventional Preventive Risk assessment) is developing a cutting-edge AI-based pre-operative test to assess patient's risk of suffering from cognitive disorders after a surgery.

Rebels 0.0%

Seed Round in 2022
Rebels 0.0% is a company dedicated to creating truly alcohol-free spirits, aiming to provide consumers with enjoyable alternatives for social drinking. By developing beverages that can be mixed with various drinks while containing no alcohol, Rebels 0.0% promotes a social mission to empower individuals in their choices regarding alcohol consumption. The brand emphasizes the importance of freedom of choice, allowing people to partake in social experiences without the effects of alcohol.

Inergio

Pre Seed Round in 2022
Inergio Sàrl, based in Lausanne, Switzerland, specializes in designing, manufacturing, and commercializing energy systems that utilize miniaturized fuel cell technology. The company offers a range of products, including InoPower 1.0, InoPower 4.0, and InoPower X.0, which cater to various sectors such as measuring stations, surveillance systems, the leisure and entertainment industry, oil and gas, and telecommunications. Inergio's innovative fuel cells are distinguished by their ability to provide ten times the power at half the weight of existing technologies, using standard fuels like butane or propane that are readily available. This modular design allows for scalability, making the technology suitable for diverse applications, from charging consumer electronics to providing auxiliary power for drones and serving as automobile fuel cells. The company has developed a working prototype and is in the process of preparing a minimal viable product to initiate pilot projects with potential partners and customers.

Hylomorph

Series B in 2021
Hylomorph AG is a MedTech company based in Zurich, Switzerland, focused on developing innovative solutions to address fibrotic encapsulation in implantable medical devices. Founded in 2014, the company specializes in a cellulose film designed to prevent the formation and adhesion of fibrotic tissue, thereby reducing the risk of implant failure. This technology is particularly applicable in cardiac and plastic surgery, where it aids surgeons during the implantation of devices such as pacemakers and neurostimulators. Hylomorph combines advanced biotechnology and surface micro-engineering to enhance the interaction between biological tissues and medical implants, ultimately aiming to improve patient outcomes and the overall quality of healthcare.

CompPair

Seed Round in 2021
CompPair Technologies Ltd. is a Swiss company founded in 2019 that specializes in the design and development of smart, bio-inspired healable structural composites aimed at enhancing the durability and sustainability of composite materials. Originating from the Laboratory for Processing of Advanced Composites at EPFL in Lausanne, CompPair has leveraged over 12 years of research in self-healing composites to create innovative solutions. The company's flagship product, smart prepreg, effectively reduces maintenance costs, facilitates damage healing, and extends the lifespan of composite structures. CompPair serves a diverse range of industries, including aerospace, automotive, wind energy, and sports, addressing critical damage issues faced by the composite materials sector.

CompPair

Seed Round in 2021
CompPair Technologies Ltd. is a Swiss company founded in 2019 that specializes in the design and development of smart, bio-inspired healable structural composites aimed at enhancing the durability and sustainability of composite materials. Originating from the Laboratory for Processing of Advanced Composites at EPFL in Lausanne, CompPair has leveraged over 12 years of research in self-healing composites to create innovative solutions. The company's flagship product, smart prepreg, effectively reduces maintenance costs, facilitates damage healing, and extends the lifespan of composite structures. CompPair serves a diverse range of industries, including aerospace, automotive, wind energy, and sports, addressing critical damage issues faced by the composite materials sector.

Typewise

Seed Round in 2020
Typewise AG, founded in 2019 and based in Binningen, Switzerland, develops an innovative keyboard app for iOS and Android that enhances the typing experience. The app features a unique hexagonal layout designed for two-thumb typing, smart autocorrection, and predictive text capabilities, supporting over 30 languages and accommodating simultaneous multilingual use. It includes a custom dictionary that adapts to users' input languages and offers specialized support for Hinglish, catering to Indian users. Typewise prioritizes user privacy by utilizing private algorithms that function offline. The app has gained significant traction, with over 800,000 downloads and 200,000 active users, and has received several accolades, including recognition at the Swiss AI Awards and the Best of Swiss App Awards. Typewise aims to simplify communication by reducing typing frustration and improving both speed and accuracy in written interactions.

Hystrix Medical

Seed Round in 2019
Hystrix Medical operates a digital marketplace that connects healthcare organizations with suppliers of medical devices and consumable products. This platform streamlines the procurement process, significantly reducing the time required for purchasing from the typical 4-6 months to a more efficient system. By providing a transparent market price landscape and facilitating one-stop contracting, Hystrix Medical enhances the efficiency of hospital procurement personnel and suppliers. The platform focuses on products that require minimal explanation, allowing for straightforward transactions. Users have reported average total cost savings of 40%, highlighting the platform's effectiveness in optimizing purchasing processes and fostering better trade relationships in the healthcare sector.

Peripal

Series B in 2019
Peripal AG develops and commercializes patient aids for home care patients in the field of dialysis. Its products include PeriSafe, the novel patient assist device for Peritoneal dialysis and PERiPLEX, the peritoneal dialysis infection diagnostic. The company’s development focuses on Peripal System, a patient aid for the chronic patient population in dialysis that supports a critical therapy step. Its Peripal System includes manual connection of tubings. The company was founded in 2015 and is based in Zurich, Switzerland.

Hylomorph

Series A in 2018
Hylomorph AG is a MedTech company based in Zurich, Switzerland, focused on developing innovative solutions to address fibrotic encapsulation in implantable medical devices. Founded in 2014, the company specializes in a cellulose film designed to prevent the formation and adhesion of fibrotic tissue, thereby reducing the risk of implant failure. This technology is particularly applicable in cardiac and plastic surgery, where it aids surgeons during the implantation of devices such as pacemakers and neurostimulators. Hylomorph combines advanced biotechnology and surface micro-engineering to enhance the interaction between biological tissues and medical implants, ultimately aiming to improve patient outcomes and the overall quality of healthcare.

Peripal

Series A in 2017
Peripal AG develops and commercializes patient aids for home care patients in the field of dialysis. Its products include PeriSafe, the novel patient assist device for Peritoneal dialysis and PERiPLEX, the peritoneal dialysis infection diagnostic. The company’s development focuses on Peripal System, a patient aid for the chronic patient population in dialysis that supports a critical therapy step. Its Peripal System includes manual connection of tubings. The company was founded in 2015 and is based in Zurich, Switzerland.
Advanced Osteotomy Tools AG is a Swiss company focused on developing innovative medical devices for osteotomy, a surgical procedure that involves cutting and reshaping bones. Established in 2010 and based in Basel, the company specializes in a computer-assisted and robot-guided laser osteotome device designed for precise functional geometrical bone cuts. This technology is applicable in cranio-maxillofacial interventions and various complex surgical procedures. Advanced Osteotomy Tools AG originated from the University Hospital and the University of Basel, transitioning into a privately owned entity in 2011, with its first funding secured in 2012. The company's mission is to advance bone surgery by utilizing laser technology, robotics, and navigation systems for a contact-free surgical experience.

Diviac

Angel Round in 2015
Diviac is the world’s leading online travel agency for scuba divers. A platform like no other, that inspires divers to dive more, travel more and take care of our oceans. Researching and booking a scuba holiday has never been easier, nor more enjoyable. Founded in December 2012 in Switzerland, Diviac is on a mission to energize and grow the overall scuba diving market for the benefit of all players. It already offers more dive destinations and more scuba holidays than any other travel company in the world. Catering to groups and individual travelers alike, Diviac uniquely combines best in class online booking experience with truly personalized expert advice, delivered by its global team of scuba travel experts. Diviac also cares deeply about sustainability and with the launch of Diviac Eco Travel, it now offers divers the opportunity to experience life-changing dive vacations that have an impact on the conservation of our oceans.

Medyria

Series A in 2015
Medyria is a Swiss medtech startup that engineers technologies for cardiovascular catheter navigation and sensing. They develop a unique guiding and sensing medical device based on proprietary Blood Flow Velocity Sensor technology. The TrackCath System is designed to be cost-effective and safe during EVAR procedures. Medyria's goal is to develop devices that enable safer and more effective endovascular procedures. It was founded in 2014 and is based in Winterthur, Zurich, Switzerland.

Bluetector

Series A in 2015
Bluetector AG, founded in 2012 and based in Root, Switzerland, specializes in wastewater treatment solutions, particularly focusing on manure and biogas digestate management. The company manufactures wastewater treatment machinery, including containerized filtering systems designed to address the challenges of excessive manure production on farms. By transforming manure into clean water, Bluetector significantly reduces the costs and logistical burdens associated with transporting manure, which can exceed $25 per cubic meter. Their innovative technology provides a more environmentally friendly and cost-effective alternative to traditional disposal methods, allowing for the sustainable reuse of wastewater. Additionally, Bluetector engages in the construction and renovation of municipal wastewater treatment plants, further contributing to effective waste management solutions.

DiviCom

Venture Round in 2014
Divicom is a group of companies specializing in health, with 16 years of history. The experience of their professionals allows Divicom the provision of high quality services with attention constant improvement of cost - effectiveness.

Creoptix

Series A in 2013
Creoptix AG is a Swiss company specializing in the development of optical instruments and consumables for label-free analysis of molecular interactions, primarily serving the drug discovery sector. Founded in 2009 and based in Wädenswil, the company provides advanced instrument sets tailored for fragment-based screening and binding analysis at low concentrations and slow dissociation kinetics. Their offerings include versatile sensors designed for carboxyl-coupling with a variety of molecules, as well as proprietary software that streamlines assay setup and data evaluation into a single platform. Creoptix aims to accelerate discovery in both industry and academic research by equipping life science researchers with innovative bioanalytical tools.

Leman Micro Devices

Series A in 2013
Leman Micro Devices SA, incorporated in 2013 and based in Lausanne, Switzerland, specializes in developing innovative technology for future smartphones. The company has introduced the V-Sensor health sensor and accompanying application, which offers a cuffless and calibration-free solution for measuring vital health metrics such as blood pressure, body temperature, blood oxygen saturation, heart rate, and respiration rate with medical accuracy. Leman Micro Devices' sensor and software system are designed to comply with international medical standards and are compact and cost-effective, enabling integration into smartphones, wearables, and other mobile devices.

Credentis

Series B in 2013
Credentis is a Swiss company founded in 2010 and based in Windisch, Aargau, specializing in the research, development, production, and distribution of innovative dental care products aimed at preventing and treating dental diseases. The company focuses on tooth regeneration and offers solutions for various dental issues, including hypersensitivity, caries lesions, and damage from bleaching. Its product lineup includes Curodont Repair, Curodont Protect, and Curodont D’Senz, which help protect and regenerate enamel and dentin, providing dentists with effective tools to enhance oral health. By addressing problems such as acid erosion and white spot lesions, Credentis aims to improve patient outcomes and promote overall dental well-being.

Attolight

Series B in 2012
Attolight specializes in developing time-resolved cathodoluminescence instruments that enhance the measurement of carrier dynamics in nanostructures. Their innovative technology integrates light and electron microscopy, allowing for efficient and streamlined experiments that were previously complex and cumbersome. With a focus on improving the efficiency of materials such as semiconductors and phosphors, Attolight's solutions offer nanometer resolution and pico-second timing for time-resolved studies. This capability enables researchers to identify ultra-trace impurities and crystallographic defects that are not detectable using conventional imaging techniques. By providing advanced tools for material analysis, Attolight is transforming the landscape of electron microscopy and ultrafast spectroscopy in the field of nanotechnology.

Viroblock

Series C in 2012
Viroblock SA is a healthcare company based in Geneva, Switzerland, established in 2005, that specializes in developing and marketing antiviral products. The company has created a novel technology that inactivates enveloped viruses, including various strains of influenza, hepatitis B and C, and the AIDS virus. This technology is integrated into non-woven fabrics, making it particularly effective for air filtration products. Viroblock's respiratory FFP2 masks are designed to provide protection against these viruses, demonstrating the capability to eliminate over 99% of H5N1 viruses in controlled experiments. The company's approach offers broad-spectrum antiviral action without leading to viral resistance, positioning it as a leader in advanced antiviral solutions for both prophylactic and therapeutic applications.

Advanced Osteotomy Tools AG

Seed Round in 2012
Advanced Osteotomy Tools AG is a Swiss company focused on developing innovative medical devices for osteotomy, a surgical procedure that involves cutting and reshaping bones. Established in 2010 and based in Basel, the company specializes in a computer-assisted and robot-guided laser osteotome device designed for precise functional geometrical bone cuts. This technology is applicable in cranio-maxillofacial interventions and various complex surgical procedures. Advanced Osteotomy Tools AG originated from the University Hospital and the University of Basel, transitioning into a privately owned entity in 2011, with its first funding secured in 2012. The company's mission is to advance bone surgery by utilizing laser technology, robotics, and navigation systems for a contact-free surgical experience.

Attolight

Seed Round in 2010
Attolight specializes in developing time-resolved cathodoluminescence instruments that enhance the measurement of carrier dynamics in nanostructures. Their innovative technology integrates light and electron microscopy, allowing for efficient and streamlined experiments that were previously complex and cumbersome. With a focus on improving the efficiency of materials such as semiconductors and phosphors, Attolight's solutions offer nanometer resolution and pico-second timing for time-resolved studies. This capability enables researchers to identify ultra-trace impurities and crystallographic defects that are not detectable using conventional imaging techniques. By providing advanced tools for material analysis, Attolight is transforming the landscape of electron microscopy and ultrafast spectroscopy in the field of nanotechnology.

VirtaMed

Seed Round in 2008
VirtaMed AG, based in Schlieren, Switzerland, develops and produces highly realistic surgical simulators specifically designed for medical training. Founded in 2007, the company offers a range of simulators for various medical specialties, including orthopedics, obstetrics and gynecology, laparoscopy, and urology, in addition to custom-made simulators. These simulators enable surgeons to train with original instruments in a safe and controlled environment, enhancing their skills before they operate on patients. VirtaMed’s advanced mixed reality technology provides sub-millimeter precision, allowing for progressively complex training scenarios that align with competency-based curricula. This innovative approach not only improves surgical education but also reduces costs associated with disposable materials during training, ultimately accelerating the time required for surgeons to achieve proficiency.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.